Home / Almujtama Alraida Medical Co. / 2023 Annual Results

Almujtama Alraida Medical Co. 2023 Annual Results

Revenue

SAR 408M

Net Profit

SAR 11M

EPS

SAR 1.20

Operating Cash Flow

SAR 68M

Almujtama Alraida Medical Co. (9592) reported full year 2023 revenue of SAR 408M, up 11.1% from SAR 367M in 2022. Net profit came in at SAR 11M, down 40.3% year on year. Earnings per share were SAR 1.20. The company generated SAR 68M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 5.98 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 5.98.

Key Financial Metrics

Metric	2023	2022
Revenue	SAR 408M	SAR 367M
Net Profit	SAR 11M	SAR 19M
Net Margin	2.8%	5.2%
ROE	8.8%	16.1%
EPS	SAR 1.20	SAR 2.01
Total Assets	SAR 442M	SAR 334M
Total Equity	SAR 130M	SAR 119M
Total Liabilities	SAR 312M	SAR 216M
Operating Cash Flow	SAR 68M	SAR 19M

Year on Year Comparison

Revenue increased by 11.1% compared to 2022. Net profit decreased by 40.3%. Revenue grew but profit declined — suggesting margin pressure.

View full company profile →

View all years:

2025 2024 2023 2022

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2024-03-31.